These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Ettinger MP. Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222 [Abstract] [Full Text] [Related]
5. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review. Martens MG. J Reprod Med; 2003 Jun 13; 48(6):425-34. PubMed ID: 12856513 [Abstract] [Full Text] [Related]
6. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture. Miller RG. Geriatrics; 2006 Jan 13; 61(1):24-30. PubMed ID: 16405361 [Abstract] [Full Text] [Related]
7. Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. Prince R, Sipos A, Hossain A, Syversen U, Ish-Shalom S, Marcinowska E, Halse J, Lindsay R, Dalsky GP, Mitlak BH. J Bone Miner Res; 2005 Sep 13; 20(9):1507-13. PubMed ID: 16059622 [Abstract] [Full Text] [Related]
8. Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis. Krege JH, Wan X. Bone; 2012 Jan 13; 50(1):161-4. PubMed ID: 22036910 [Abstract] [Full Text] [Related]
10. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis. Makras P, Hamdy NA, Zwinderman AH, Ballieux BE, Papapoulos SE. Bone; 2009 May 13; 44(5):766-71. PubMed ID: 19442613 [Abstract] [Full Text] [Related]
11. Strategies for treatment to prevent fragility fractures in postmenopausal women. Geusens P. Best Pract Res Clin Rheumatol; 2009 Dec 13; 23(6):727-40. PubMed ID: 19945685 [Abstract] [Full Text] [Related]
12. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ. Arthritis Rheum; 2008 Jun 13; 58(6):1687-95. PubMed ID: 18512789 [Abstract] [Full Text] [Related]
13. [Osteoporosis]. Uebelhart B, Rizzoli R. Rev Med Suisse; 2010 Jan 13; 6(231):56-60, 62. PubMed ID: 20196435 [Abstract] [Full Text] [Related]
15. Clinical and therapeutic aspects of osteoporosis. Compston J. Eur J Radiol; 2009 Sep 13; 71(3):388-91. PubMed ID: 19660883 [Abstract] [Full Text] [Related]
16. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Kanis JA, Johansson H, Oden A, McCloskey EV. Bone; 2009 Jun 13; 44(6):1049-54. PubMed ID: 19254788 [Abstract] [Full Text] [Related]
17. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women]. Gorai I, World Health Organization. Clin Calcium; 2007 Jul 13; 17(7):1090-6. PubMed ID: 17607077 [Abstract] [Full Text] [Related]
18. Effective strategies to identify postmenopausal women at risk for osteoporosis. Levine JP. Geriatrics; 2007 Nov 13; 62(11):22-30. PubMed ID: 17999567 [Abstract] [Full Text] [Related]
19. Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women. Ettinger B, Hillier TA, Pressman A, Che M, Hanley DA. J Womens Health (Larchmt); 2005 Mar 13; 14(2):159-71. PubMed ID: 15775734 [Abstract] [Full Text] [Related]
20. [How to prevent early postmenopausal fracture risk? Proposition of a strategy]. Trémollieres F, Pouilles JM, Ribot C. Gynecol Obstet Fertil; 2009 Jan 13; 37(1):50-6. PubMed ID: 19110461 [Abstract] [Full Text] [Related] Page: [Next] [New Search]